Serum calprotectin levels as markers of inflammation, insulin resistance and hyperandrogenism in women with polycystic ovary syndrome
Open Access
- 23 December 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (51) , e32326
Abstract
Polycystic ovary syndrome (PCOS) is a common, complex endocrine, and metabolic disorder. Inflammation has been thought to play an important role in PCOS pathogenesis in recent years, and various inflammatory markers have been investigated; however, no definite conclusion has been reached. As a multifunctional regulatory protein in different inflammatory processes, calprotectin may play a role in the etiology of PCOS. Therefore, based on this hypothesis, we aimed to determine serum calprotectin concentrations in women with PCOS and to compare them with healthy controls. This cross-sectional study was conducted at a tertiary referral center during the study period. Forty-three women (n = 43) with PCOS and 47 women (n = 47) in the control group were enrolled in this cross-sectional study. Serum calprotectin concentrations were measured using enzyme-linked immunosorbent assay and compared with markers of glucose and lipid metabolism. Clinical characteristics and hormonal parameters were evaluated in both groups. Levels of serum calprotectin were measured as 347 ± 28.8 and 188 ± 15.3 ng/mL in the PCOS and healthy control groups, respectively (P = .009). The mean homeostatic model assessment for insulin resistance[1] index and total testosterone levels were significantly higher in the PCOS group than in the control group (both P < .001). Spearman’s correlation test demonstrated linear correlations between calprotectin and C-reactive protein, waist circumference, insulin resistance index, and total testosterone levels in the PCOS group (all P < .05). Serum calprotectin levels were higher in women with PCOS. This biomarker may be an indirect sign of insulin resistance, hyperandrogenism, or chronic inflammation in women with PCOS.Keywords
This publication has 26 references indexed in Scilit:
- A indicator of visceral adipose dysfunction to evaluate metabolic health in adult ChineseScientific Reports, 2016
- Calprotectin is a potential prognostic marker for polycystic ovary syndromeAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2016
- Optimal cut-off values for the homeostasis model assessment of insulin resistance (HOMA-IR) and pre-diabetes screening: Developments in research and prospects for the futureDrug Discoveries & Therapeutics, 2015
- High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS)Gynecological Endocrinology, 2014
- Resveratrol potentiates effects of simvastatin on inhibition of rat ovarian theca-interstitial cells steroidogenesisJournal of Ovarian Research, 2014
- Inflammation in Polycystic Ovary Syndrome: Underpinning of insulin resistance and ovarian dysfunctionSteroids, 2012
- Increased Levels of Calprotectin in Obesity Are Related to Macrophage Content: Impact on Inflammation and Effect of Weight LossMolecular Medicine, 2011
- Neutrophil Activation in Morbid Obesity, Chronic Activation of Acute InflammationObesity, 2009
- European Multicenter Tacrolimus (FK506) Heart Pilot Study: one-year results--European Tacrolimus Multicenter Heart Study Group.1998
- Influence of Type of Surgery on the Occurrence of Parasympathetic Reinnervation After Cardiac TransplantationCirculation, 1998